Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Italy.

Specchia, M. L., De Waure, C., Gualano, M., Doria, A., Turchetti, G., Pippo, L., Di Nardo, F., Capizzi, S., Cadeddu, C., Kheiraoui, F., Iaccarino, L., Pierotti, F., Palla, I., Veneziano, M. A., Gliubizzi, M. D., Sferrazza, A., Nicolotti, N., Porcasi, R., La Torre, G., Di Pietro, M. L., Ricciardi, W., Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus, <<BIOMED RESEARCH INTERNATIONAL>>, 2014; 2014 (N/A): 704207-704215. [doi:10.1155/2014/704207] [http://hdl.handle.net/10807/64076]

Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus

Specchia, Maria Lucia;De Waure, Chiara;Di Nardo, Francesco;Capizzi, Silvio;Cadeddu, Chiara;Veneziano, Maria Assunta;Gliubizzi, Maria Daniela;Sferrazza, Antonella;Nicolotti, Nicola;La Torre, Giuseppe;Di Pietro, Maria Luisa;Ricciardi, Walter
2014

Abstract

Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Italy.
2014
Inglese
Specchia, M. L., De Waure, C., Gualano, M., Doria, A., Turchetti, G., Pippo, L., Di Nardo, F., Capizzi, S., Cadeddu, C., Kheiraoui, F., Iaccarino, L., Pierotti, F., Palla, I., Veneziano, M. A., Gliubizzi, M. D., Sferrazza, A., Nicolotti, N., Porcasi, R., La Torre, G., Di Pietro, M. L., Ricciardi, W., Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus, <<BIOMED RESEARCH INTERNATIONAL>>, 2014; 2014 (N/A): 704207-704215. [doi:10.1155/2014/704207] [http://hdl.handle.net/10807/64076]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/64076
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 7
social impact